April 14, 2008

Sabinsa Corporation today announced that it has secured a U.S. patent for its branded ingredient Cococin™, a freeze-dried powder form of green coconut water. In addition to Sabinsa's derivation process, U.S. patent #7,300,682 secures exclusive rights to the resulting vitamin-rich composition and its intended uses in cosmetics, supplements and foods and beverages to support healthy cell growth and improve overall dermal health, among others.

"Coconut water's staggering level of active ingredients provides an exceptionally rich repository of vitamins, minerals and amino, shikimic and quinic acids essential for healthy tissue growth, resulting in an optimal ingredient for today's cosmeceutical market," said Dr. Lakshmi Prakash, vice president of innovation and business development, Sabinsa Corporation. "We have worked diligently to secure this processs, composition and use patent to ensure a safe and efficacious ingredient resulting from Sabinsa's high-quality, nutrient-preserving freeze-dried process."

Sabinsa's process extracts green coconut water, a liquid endosperm of maturing coconut, at optimal maturity when high levels of RNA, critical for amino acid transport and respiratory metabolism of living cells, are present. Long considered a refreshing beverage and even a natural sports drink in Southeast Asia, Central America and other tropical regions, green coconut water has been valued for its regenerative benefits.

In addition to Cococin's U.S. protection, the branded ingredient was also granted European Patent #EP1341547 for process, composition and use in the European Market.

Sabinsa Corporation is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Celebrating its 20th year servicing the natural products industry, Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and wellbeing. Over the past several years, the company has brought to market more than 50 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. Sabinsa has six state-of-the-art manufacturing facilities in India dedicated to the production of herbal extracts, phytochemicals, biotech ingredients and supercritical extracts. In the U.S., the company operates a 42,000-square-foot facility in Payson, Utah, which provides cutting-edge capabilities for the development of capsules, tablets, bulk custom premixes, drum-to-hopper blends, stick packs and powdered drinks. All of Sabinsa's facilities use effluent water treatment systems and are environmentally conscious and friendly. All products are intended for human consumption and certified Kosher. For more information visit www.sabinsa.com.